» Articles » PMID: 3122216

Molecular Basis of the Cell-surface Expression of Immunoglobulin Mu Chain Without Light Chain in Human B Lymphocytes

Overview
Specialty Science
Date 1987 Dec 1
PMID 3122216
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Four distinct human B-lymphoid cell lines possess the ability to circumvent the mechanism regulating intracellular transport of immunoglobulin protein. These cells do not produce light chains, yet they express mu heavy chains on the cell surface at comparable levels to B-cell lines that produce native forms of both proteins. The mu-chain mRNA produced in all four cell lines was found to contain an identical deletion of most of the heavy-chain variable (VH) region (75% of the 3' portion), with no apparent alteration in constant (C) region structure. The truncated mu (mu*)-chain mRNA in these cells was created through the use of a cryptic splice donor site found within the human VH gene(s) utilized by these B-cell lines. The truncated mu chains exhibited a decreased ability to associate with the intracellular transport regulatory protein, heavy-chain binding protein (BiP). This result indicates that VH region structure, in addition to C mu 1 region structure, influences the formation of the BiP recognition site on the heavy chain. Furthermore, it suggests that the mechanism allowing for cell-surface expression of the mu* chains in the absence of light-chain pairing is the inability of BiP to bind to the mu* chains and hence prevent their intracellular transport. The high frequency with which the mu-only surface immunoglobulin positive phenotype is present in our collection of human B-cell lines and the isolation of one of the cell lines from a healthy individual also suggest that B cells of this type may represent a significant subpopulation among the normal human B-cell repertoire.

Citing Articles

Immunoglobulin gamma 2b transgenes inhibit heavy chain gene rearrangement, but cannot promote B cell development.

Roth P, Doglio L, Manz J, Kim J, Lo D, STORB U J Exp Med. 1993; 178(6):2007-21.

PMID: 8245779 PMC: 2191288. DOI: 10.1084/jem.178.6.2007.


Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.

Taylor K, Wetzel S, Lyles D, Pollok B J Virol. 1994; 68(10):6421-31.

PMID: 8083980 PMC: 237062. DOI: 10.1128/JVI.68.10.6421-6431.1994.


An aberrant splicing using a 3' cryptic splice site within the CH1 exon induces truncated mu-chain production.

Komori T, Sugiyama H Immunology. 1995; 85(1):166-70.

PMID: 7635518 PMC: 1384041.


Clonal diversity in the B cell repertoire of patients with X-linked agammaglobulinemia.

Anker R, Conley M, Pollok B J Exp Med. 1989; 169(6):2109-19.

PMID: 2786547 PMC: 2189345. DOI: 10.1084/jem.169.6.2109.


Translocation t(14;18) in B cell lymphomas as a cause for defective immunoglobulin production.

de Jong D, Voetdijk B, van Ommen G, Kluin-Nelemans J, Beverstock G, Kluin P J Exp Med. 1989; 169(3):613-24.

PMID: 2538543 PMC: 2189270. DOI: 10.1084/jem.169.3.613.


References
1.
Marchalonis J . An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J. 1969; 113(2):299-305. PMC: 1184636. DOI: 10.1042/bj1130299. View

2.
Hendershot L, Bole D, Kohler G, Kearney J . Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein. J Cell Biol. 1987; 104(3):761-7. PMC: 2114523. DOI: 10.1083/jcb.104.3.761. View

3.
Rigby P, Dieckmann M, Rhodes C, Berg P . Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol. 1977; 113(1):237-51. DOI: 10.1016/0022-2836(77)90052-3. View

4.
Morrison S . Murine heavy chain disease. Eur J Immunol. 1978; 8(3):194-9. DOI: 10.1002/eji.1830080311. View

5.
Schibler U, Marcu K, PERRY R . The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells. Cell. 1978; 15(4):1495-509. DOI: 10.1016/0092-8674(78)90072-7. View